Abiopharma

New Form 8-K - Alaunos Therapeutics, Inc. Filed: 2025-07-10 AccNo: 0000950170-25-095029 Size: 272 KB Item 3.03: Material Modifications to Rights of Security Holders Item 5.07: Submission of Matters to a Vote of Security Holders Item 9.01: Financial Statements and Exhibits